ArticleOncoTargets and therapy2018

Efficacy and safety of weekly nab-paclitaxel plus cisplatin with concurrent intensity-modulated radiotherapy in patients with inoperable, locally advanced esophageal cancer: a pilot trial.

Daquan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.